株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

大腸癌診断検査の世界市場:医療機器のパイプライン評価

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 366599
出版日 ページ情報 英文 439 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
大腸癌診断検査の世界市場:医療機器のパイプライン評価 Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月15日 ページ情報: 英文 439 Pages
概要

当レポートでは、世界の大腸癌 (結腸直腸癌) 診断検査の関連製品の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 大腸癌診断検査の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 大腸癌診断検査の企業:治験段階別のパイプライン製品
  • 大腸癌診断検査:治験段階別のパイプライン製品

第5章 大腸癌診断検査市場:企業・製品の概要 (全119社分)

  • A2K Technologies
  • Abbott Diagnostics
  • Abcodia Ltd.
  • Acobiom
  • Advanced Marker Discovery, S.L.
  • Advpharma Inc.
  • Ambergen, Inc.
  • Ambrilia Biopharma Inc.
  • Arizona State University
  • ArtemixRx
  • Asuragen, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Biotechnostics GmbH
  • BioTime, Inc.
  • Biotron Limited
  • Castle Biosciences Incorporated
  • Cellmid Limited
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • China Sky One Medical, Inc.
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • ColoPrev
  • Columbia University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Di.V.A.L Toscana srl
  • Diadexus Inc
  • DiagnoCure Inc.
  • Diaxonhit S.A.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eventus Diagnostics, Inc.
  • Exact Sciences Corporation
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech
  • GenomicTree, Inc.
  • Ghent University
  • GlycoZym
  • Health Discovery Corporation
  • Human Metabolome Technologies, Inc.
  • Ikonisys, Inc.
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Lab21 Limited
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Lightsphere Diagnostics
  • LX Diagnostics
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Merrimack Pharmaceuticals, Inc.
  • Metabiomics Corporation
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • MetaStat, Inc.
  • Milagen, Inc.
  • Miraculins Inc.
  • Mode Dx Ltd.
  • Moscow Institute of Physics and Technology
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • NetScientific Plc
  • Norda ASA
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc.
  • Nuvera Biosciences, Inc.
  • Oncimmune (USA) LLC
  • OncoVista Innovative Therapies, Inc.
  • On-Q-ity, Inc. (Inactive)
  • Origin Sciences Limited
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers
  • Oxford Gene Technology Limited
  • Panacea Pharmaceuticals, Inc.
  • PleX Diagnostics
  • Precision Biologics, Inc.
  • Prediction Sciences
  • Protagen AG
  • Rabin Medical Center
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene, Inc.
  • Shuwen Biotech Co. Ltd.
  • Siamab Therapeutics, Inc.
  • Skuldtech France
  • シスメックス
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Theranostics Health, Inc.
  • Todos Medical Company Overview
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alabama at Birmingham
  • University of Illinois at Chicago
  • University of Texas at Austin
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vermillion, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.
  • XEPTAGEN SpA

第6章 大腸癌診断検査市場市場:昨今の動向 (全99件)

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
  • Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26
  • Table 6: Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
  • Table 7: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 32
  • Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 9: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status 37
  • Table 10: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description 37
  • Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 12: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status 38
  • Table 13: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Description 38
  • Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 15: Veracode - Colorectal Cancer Diagnostic Tests - Product Status 39
  • Table 16: Veracode - Colorectal Cancer Diagnostic Tests - Product Description 39
  • Table 17: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 18: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status 40
  • Table 19: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description 40
  • Table 20: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 21: Cchek - Colon Cancer Confirmatory Test - Product Status 41
  • Table 22: Cchek - Colon Cancer Confirmatory Test - Product Description 41
  • Table 23: Cchek - Colon Cancer Recurrence Test - Product Status 42
  • Table 24: Cchek - Colon Cancer Recurrence Test - Product Description 42
  • Table 25: Cchek - Colon Cancer Screening Test - Product Status 42
  • Table 26: Cchek - Colon Cancer Screening Test - Product Description 43
  • Table 27: Cchek - Colon Cancer Treatment Monitoring Test - Product Status 43
  • Table 28: Cchek - Colon Cancer Treatment Monitoring Test - Product Description 43
  • Table 29: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview 44
  • Table 30: Cchek - Colon Cancer Screening Test - Cchek Cancer Patient Efficacy Study 45
  • Table 31: Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 45
  • Table 32: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 33: SimpliPro Colon-A - Product Status 46
  • Table 34: SimpliPro Colon-A - Product Description 46
  • Table 35: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 36: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status 47
  • Table 37: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description 47
  • Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 39: Finger Stick Test - Colon Cancer - Product Status 48
  • Table 40: Finger Stick Test - Colon Cancer - Product Description 48
  • Table 41: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Status 49
  • Table 43: ArtemixRx Prognostic Test - Colon Cancer - Product Description 49
  • Table 44: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 45: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status 50
  • Table 46: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description 50
  • Table 47: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 48: Diagnostic Test - Colorectal Adenoma - Product Status 51
  • Table 49: Diagnostic Test - Colorectal Adenoma - Product Description 51
  • Table 50: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 51: Idylla MSI CDx - Product Status 52
  • Table 52: Idylla MSI CDx - Product Description 52
  • Table 53: Idylla MSI Test - Product Status 53
  • Table 54: Idylla MSI Test - Product Description 53
  • Table 55: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 56: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status 54

List of Figures

  • Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
  • Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26
目次
Product Code: GDME0837EPD

GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables 12
  • 1.2 List of Figures 20

2 Introduction 21

  • 2.1 Colorectal Cancer Diagnostic Tests Overview 21

3 Products under Development 22

  • 3.1 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
  • 3.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
  • 3.3 Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
  • 3.4 Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
  • 3.5 Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26

4 Colorectal Cancer Diagnostic Tests - Pipeline Products under Development by Companies 27

  • 4.1 Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
  • 4.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 32

5 Colorectal Cancer Diagnostic Tests Companies and Product Overview 37

6 Colorectal Cancer Diagnostic Tests - Recent Developments 195

7 Appendix 427

Back to Top